Neumora Therapeutics, Inc.
Recent Filings
All 226 filings →| Form | Description | Date |
|---|---|---|
| SCHEDULE 13G | — | Feb 19, 2026 |
| 4 | — | Feb 19, 2026 |
| 4 | — | Feb 19, 2026 |
| 4 | — | Feb 19, 2026 |
| 4 | — | Feb 19, 2026 |
| 144 | — | Feb 17, 2026 |
| 144 | — | Feb 17, 2026 |
| SCHEDULE 13G/A | — | Feb 17, 2026 |
| 144 | — | Feb 17, 2026 |
| 144 | — | Feb 17, 2026 |
Insider Transactions
View all →| Insider | Title | Type | Shares | Date |
|---|---|---|---|---|
| Aurora Daljit Singh | See Remarks | Sale | 114,703 @ $2.68 | Nov 11, 2025 |
| Burow Kristina | — | Purchase | 1,915,700 @ $2.61 | Oct 27, 2025 |
| ARCH Venture Partners XII, LLC | — | Purchase | 1,915,700 @ $2.61 | Oct 27, 2025 |
| ARCH Venture Partners VIII, LLC | — | Purchase | 1,915,700 @ $2.61 | Oct 27, 2025 |
| BERNS PAUL L | See Remarks | Sale | 13,871 @ $1.69 | Feb 18, 2025 |
| Milligan Michael Lee | See Remarks | Sale | 1,978 @ $1.69 | Feb 18, 2025 |
| Aurora Daljit Singh | Chief Strategy Officer | Sale | 8,565 @ $1.68 | Feb 18, 2025 |
| Lenz Robert A. | Head of R&D | Sale | 5,614 @ $1.67 | Feb 18, 2025 |
| Pinto Joshua | President | Sale | 8,048 @ $1.67 | Feb 18, 2025 |
| Fust Matthew K | — | Sale | 14,049 @ $17.03 | Oct 18, 2024 |